Kazem Javanmardi

522 total citations
26 papers, 427 citations indexed

About

Kazem Javanmardi is a scholar working on Cellular and Molecular Neuroscience, Surgery and Pharmacology. According to data from OpenAlex, Kazem Javanmardi has authored 26 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 5 papers in Surgery and 5 papers in Pharmacology. Recurrent topics in Kazem Javanmardi's work include Hormonal Regulation and Hypertension (5 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (4 papers) and Pain Mechanisms and Treatments (4 papers). Kazem Javanmardi is often cited by papers focused on Hormonal Regulation and Hypertension (5 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (4 papers) and Pain Mechanisms and Treatments (4 papers). Kazem Javanmardi collaborates with scholars based in Iran, Japan and Poland. Kazem Javanmardi's co-authors include Parisa Hasanein, Mansoor Keshavarz, Hiva Alipanah, Mohammad Allahtavakoli, Mohammad Raman Moloudi, Mohammad Kazemi Arababadi, Ali Shamsizadeh, Hamid Najafipour, Saeed Esmaeili‐Mahani and Naser Mirazi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain Research and European Journal of Pharmacology.

In The Last Decade

Kazem Javanmardi

26 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazem Javanmardi Iran 13 107 92 89 88 83 26 427
Scott Whyte Australia 15 82 0.8× 82 0.9× 67 0.8× 324 3.7× 228 2.7× 29 796
Farzad Ebrahimi Iran 11 58 0.5× 115 1.3× 40 0.4× 57 0.6× 112 1.3× 33 481
Yuping Liu China 13 68 0.6× 34 0.4× 49 0.6× 68 0.8× 120 1.4× 64 559
Dae Hyun Kim South Korea 14 129 1.2× 52 0.6× 22 0.2× 67 0.8× 71 0.9× 64 704
Jin A Yoon South Korea 15 44 0.4× 28 0.3× 74 0.8× 80 0.9× 132 1.6× 80 727
Dae-Young Kim South Korea 13 49 0.5× 29 0.3× 70 0.8× 94 1.1× 75 0.9× 61 502
Saku Ruohonen Finland 15 25 0.2× 133 1.4× 123 1.4× 144 1.6× 124 1.5× 33 587
Haibo Wu China 13 34 0.3× 49 0.5× 122 1.4× 72 0.8× 80 1.0× 43 437
Yoshinobu Nagasawa Japan 13 23 0.2× 58 0.6× 248 2.8× 85 1.0× 155 1.9× 56 504
Hiroo Takeda Japan 14 49 0.5× 133 1.4× 45 0.5× 200 2.3× 168 2.0× 30 863

Countries citing papers authored by Kazem Javanmardi

Since Specialization
Citations

This map shows the geographic impact of Kazem Javanmardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazem Javanmardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazem Javanmardi more than expected).

Fields of papers citing papers by Kazem Javanmardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazem Javanmardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazem Javanmardi. The network helps show where Kazem Javanmardi may publish in the future.

Co-authorship network of co-authors of Kazem Javanmardi

This figure shows the co-authorship network connecting the top 25 collaborators of Kazem Javanmardi. A scholar is included among the top collaborators of Kazem Javanmardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazem Javanmardi. Kazem Javanmardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Javanmardi, Kazem, et al.. (2025). Protective effects of Alamandine against doxorubicin-induced liver injury in rats. BMC Pharmacology and Toxicology. 26(1). 95–95. 1 indexed citations
2.
Javanmardi, Kazem, et al.. (2024). Dexamethasone release from hyaluronic acid microparticle and proanthocyanidin-gelatin hydrogel in sciatic tissue regeneration. Journal of Materials Science Materials in Medicine. 35(1). 5–5. 9 indexed citations
3.
Javanmardi, Kazem, et al.. (2024). Effects of alamandine on monocrotaline-induced pulmonary hypertension in rats.. SHILAP Revista de lepidopterología. 27(4). 500–508. 4 indexed citations
4.
5.
Gholami, Zahra, et al.. (2023). Alamandine injection in the periaqueductal gray and rostral ventromedial medulla attenuates allodynia induced by sciatic nerve ligation in rats. Neuroscience Letters. 818. 137568–137568. 2 indexed citations
6.
Javanmardi, Kazem, et al.. (2021). Possible Risk of Thrombotic Events following Oxford‐AstraZeneca COVID‐19 Vaccination in Women Receiving Estrogen. BioMed Research International. 2021(1). 7702863–7702863. 5 indexed citations
7.
Alipanah, Hiva, et al.. (2021). Protective effect of alamandine on doxorubicin‑induced nephrotoxicity in rats. BMC Pharmacology and Toxicology. 22(1). 31–31. 50 indexed citations
8.
Javanmardi, Kazem, et al.. (2017). Differences in Cardiovascular Responses to Alamandine in Two-Kidney, One Clip Hypertensive and Normotensive Rats. Circulation Journal. 81(3). 405–412. 25 indexed citations
9.
Heydari, Seyed Taghi, Mehrdad Vossoughi, Kamran Bagheri Lankarani, et al.. (2016). Prevalence and risk factors of alcohol and substance abuse among motorcycle drivers in Fars province, Iran. Chinese Journal of Traumatology. 19(2). 79–84. 31 indexed citations
10.
Najafipour, Hamid, et al.. (2011). Cardiovascular responses to apelin in two-kidney–one-clip hypertensive rats and its receptor expression in ischemic and non-ischemic kidneys. Regulatory Peptides. 172(1-3). 62–68. 31 indexed citations
11.
Allahtavakoli, Mohammad, Mohammad Raman Moloudi, Mohammad Kazemi Arababadi, Ali Shamsizadeh, & Kazem Javanmardi. (2009). Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat. Brain Research. 1271. 121–127. 38 indexed citations
12.
Hasanein, Parisa & Kazem Javanmardi. (2008). A potent and selective inhibitor of endocannabinoid uptake, UCM707, potentiates antinociception induced by cholestasis. Fundamental and Clinical Pharmacology. 22(5). 517–522. 9 indexed citations
13.
Hasanein, Parisa, Naser Mirazi, & Kazem Javanmardi. (2008). GABAA receptors in the central nucleus of amygdala (CeA) affect on pain modulation. Brain Research. 1241. 36–41. 19 indexed citations
14.
Hasanein, Parisa, et al.. (2007). CB1 RECEPTOR ACTIVATION IN THE BASOLATERAL AMYGDALA PRODUCES ANTINOCICEPTION IN ANIMAL MODELS OF ACUTE AND TONIC NOCICEPTION. Clinical and Experimental Pharmacology and Physiology. 34(5-6). 439–449. 37 indexed citations
15.
Hasanein, Parisa, et al.. (2006). Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate. European Journal of Pharmacology. 554(2-3). 123–127. 24 indexed citations
16.
Hasanein, Parisa, et al.. (2006). Oral magnesium administration prevents thermal hyperalgesia induced by diabetes in rats. Diabetes Research and Clinical Practice. 73(1). 17–22. 24 indexed citations
17.
Javanmardi, Kazem, et al.. (2005). INVOLVEMENT OFN‐METHYL‐d‐ASPARTATE RECEPTORS and NITRIC OXIDE IN THE ROSTRAL VENTROMEDIAL MEDULLA IN MODULATING MORPHINE PAIN‐INHIBITORY SIGNALS FROM THE PERIAQUEDUCTAL GREY MATTER IN RATS. Clinical and Experimental Pharmacology and Physiology. 32(7). 585–589. 30 indexed citations
18.
Foroumadi, Alireza, et al.. (2002). Synthesis and calcium channel antagonist activity of nifedipine analogues with methylthioimidazole substituent. Il Farmaco. 57(3). 195–199. 7 indexed citations
19.
Javanmardi, Kazem, et al.. (1995). Interfacial Sealing Properties of Slag Mix (Mud-to-Cement Conversion Technology): Laboratory and Field Evaluation. Proceedings of SPE/IADC Drilling Conference. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scott Whyte Breakdown of academic impact, for papers by Farzad Ebrahimi Breakdown of academic impact, for papers by Yuping Liu Breakdown of academic impact, for papers by Dae Hyun Kim Breakdown of academic impact, for papers by Jin A Yoon Breakdown of academic impact, for papers by Dae-Young Kim Breakdown of academic impact, for papers by Saku Ruohonen Breakdown of academic impact, for papers by Haibo Wu Breakdown of academic impact, for papers by Yoshinobu Nagasawa Breakdown of academic impact, for papers by Hiroo Takeda
Rankless by CCL
2026